Exploring how couples cope with breast cancer
Breast Cancer, Resilience, Quality of Life and Depression in Couples From Diagnosis to 24 Months Later: Prospective Pilot Study
This study looks at how couples handle the challenges of breast cancer over two years to see what helps them cope and stay strong together.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 40 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | Regina Elena Cancer Institute Academic / other |
| Locations | 1 site (Roma, Rome) |
| Trial ID | NCT06875414 on ClinicalTrials.gov |
What this trial studies
This observational study investigates the coping strategies of couples when one partner is diagnosed with breast cancer, focusing on their attitudes and resilience over a 24-month period. Participants include women diagnosed with stage 1, 2, or 3 breast cancer and their partners, who will complete questionnaires and participate in focus groups to provide insights into their experiences. The study aims to understand how couples adapt to the stress of illness and the impact on their quality of life.
Who should consider this trial
Good fit: Ideal candidates are women aged over 18 diagnosed with stage 1, 2, or 3 breast cancer and their partners who have lived together for at least 6 months.
Not a fit: Patients with cognitive deficits or those unable to comply with study requirements may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance support strategies for couples dealing with breast cancer, improving their overall quality of life.
How similar studies have performed: While studies on couple dynamics in chronic illness exist, this specific focus on breast cancer resilience is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
INCLUSION CRITERIA: * Woman diagnosed with stage 1, 2 or 3 breast cancer * age\> 18 years (patient and partner) * The partner must have lived with the woman for at least 6 months at diagnosis and treatment * Patients under treatment at the radiotherapy clinic * Subjects available and able to answer questionnaires, interviews, and / or participate in focus groups * Informed consent EXCLUSION CRITERIA: Cognitive deficits and / or inability to comply with the provisions of the study
Where this trial is running
Roma, Rome
- IRCCS Regina Elena National Cancer Institute — Roma, Rome, Italy (Recruiting)
Study contacts
- Study coordinator: Ilaria Farina, MSN
- Email: ilaria.farina@ifo.it
- Phone: 0652666804
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.